Atlas Trials

First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment (RAAFT-3)

Clinical trial NCT04037397 · COMPLETED

Trial details

NCT number
NCT04037397
Sponsor
University of Pennsylvania
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Atrial Fibrillation
Start date
2019-09-24
Primary completion
2024-10-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.